company background image
DVLA logo

Darya-Varia Laboratoria IDX:DVLA Stock Report

Last Price

Rp1.46k

Market Cap

Rp1.6t

7D

5.0%

1Y

-26.1%

Updated

28 Mar, 2024

Data

Company Financials

PT Darya-Varia Laboratoria Tbk

IDX:DVLA Stock Report

Market Cap: Rp1.6t

DVLA Stock Overview

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia.

DVLA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends3/6

PT Darya-Varia Laboratoria Tbk Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Darya-Varia Laboratoria
Historical stock prices
Current Share PriceRp1,460.00
52 Week HighRp2,110.00
52 Week LowRp1,375.00
Beta-0.13
1 Month Change-11.25%
3 Month Change-12.31%
1 Year Change-26.08%
3 Year Change-39.17%
5 Year Change-33.03%
Change since IPO71.76%

Recent News & Updates

Recent updates

Shareholder Returns

DVLAID PharmaceuticalsID Market
7D5.0%0.09%-0.07%
1Y-26.1%-26.2%7.0%

Return vs Industry: DVLA matched the ID Pharmaceuticals industry which returned -26.2% over the past year.

Return vs Market: DVLA underperformed the ID Market which returned 7% over the past year.

Price Volatility

Is DVLA's price volatile compared to industry and market?
DVLA volatility
DVLA Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement3.6%
Market Average Movement4.9%
10% most volatile stocks in ID Market11.6%
10% least volatile stocks in ID Market2.3%

Stable Share Price: DVLA has not had significant price volatility in the past 3 months.

Volatility Over Time: DVLA's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19761,271n/ahttps://www.darya-varia.com

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company provides prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems.

PT Darya-Varia Laboratoria Tbk Fundamentals Summary

How do Darya-Varia Laboratoria's earnings and revenue compare to its market cap?
DVLA fundamental statistics
Market capRp1.64t
Earnings (TTM)Rp146.34b
Revenue (TTM)Rp1.89t

11.2x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DVLA income statement (TTM)
RevenueRp1.89t
Cost of RevenueRp915.65b
Gross ProfitRp975.24b
Other ExpensesRp828.90b
EarningsRp146.34b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)130.66
Gross Margin51.58%
Net Profit Margin7.74%
Debt/Equity Ratio0%

How did DVLA perform over the long term?

See historical performance and comparison

Dividends

8.3%

Current Dividend Yield

162%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.